Přehled o publikaci
2024
Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI
HLINOMAZ, Ota; Zuzana MOTOVSKA; Petr KALA; Milan HROMADKA; Jan PRECEK et. al.Basic information
Original name
Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI
Authors
HLINOMAZ, Ota; Zuzana MOTOVSKA; Petr KALA; Milan HROMADKA; Jan PRECEK; Jan MROZEK; Pavel ČERVINKA; Jiri KETTNER; Jan MATEJKA; Ahmad ZOHOOR; Josef BIS and Jiří JARKOVSKÝ
Edition
Hellenic Journal of Cardiology, AMSTERDAM, ELSEVIER, 2024, 1109-9666
Other information
Language
English
Type of outcome
Article in a journal
Country of publisher
Netherlands
Confidentiality degree
is not subject to a state or trade secret
References:
Organization
Lékařská fakulta – Repository – Repository
UT WoS
001227067900001
EID Scopus
2-s2.0-85170086758
Keywords in English
Acute myocardial infarction; Cardiogenic shock; Multivessel disease; Culprit vessel primary angioplasty; Multivessel primary angioplasty
Links
LM2023049, research and development project. LX22NPO5104, research and development project. NV19-02-00086, research and development project.
Changed: 22/1/2025 00:50, RNDr. Daniel Jakubík
Abstract
V originále
lt; 0.001). Intra-aortic balloon pump, extracorporeal membrane oxygenation (ECMO), and other mechanical circulatory support systems were more often used in patients with MV-pPCI. Thirty (30)-day and 1-year all-cause mortality rates were similar in the CV-pPCI and MV-pPCI groups (odds ratio, 1.01; 95% confidence interval [CI] 0.77 to 1.32; p = 0.937 and 1.1; 95% CI 0.84 to 1.44; p = 0.477). The presence of 3-vessel disease and the use of ECMO were the strongest adjusted predictors of 30-day and 1-year mortality. Conclusions Our data from an extensive all-comers registry suggests that selective use of MV-pPCI does not increase the all-cause mortality rate in patients with CS-STEMI and MVD compared to CV-pPCI.
